Fungal Infections in Immunocompromised Hosts

This book is a printed edition of the Special Issue Fungal Infections in Immunocompromised Hosts that was published in JoF

Saved in:
Bibliographic Details
Main Author: Kontoyiannis, Dimitrios P. (auth)
Other Authors: Slavin, Monica (auth)
Format: Electronic Book Chapter
Language:English
Published: MDPI - Multidisciplinary Digital Publishing Institute 2019
Subjects:
Online Access:DOAB: download the publication
DOAB: description of the publication
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000naaaa2200000uu 4500
001 doab_20_500_12854_48211
005 20210211
003 oapen
006 m o d
007 cr|mn|---annan
008 20210211s2019 xx |||||o ||| 0|eng d
020 |a books978-3-03897-717-9 
020 |a 9783038977162 
040 |a oapen  |c oapen 
024 7 |a 10.3390/books978-3-03897-717-9  |c doi 
041 0 |a eng 
042 |a dc 
072 7 |a PS  |2 bicssc 
100 1 |a Kontoyiannis, Dimitrios P.  |4 auth 
700 1 |a Slavin, Monica  |4 auth 
245 1 0 |a Fungal Infections in Immunocompromised Hosts 
260 |b MDPI - Multidisciplinary Digital Publishing Institute  |c 2019 
300 |a 1 electronic resource (212 p.) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
506 0 |a Open Access  |2 star  |f Unrestricted online access 
520 |a This book is a printed edition of the Special Issue Fungal Infections in Immunocompromised Hosts that was published in JoF 
540 |a Creative Commons  |f https://creativecommons.org/licenses/by-nc-nd/4.0/  |2 cc  |4 https://creativecommons.org/licenses/by-nc-nd/4.0/ 
546 |a English 
650 7 |a Biology, life sciences  |2 bicssc 
653 |a toxicity 
653 |a risk assessment 
653 |a species complex 
653 |a galactomannan 
653 |a taxonomy 
653 |a Aspergillus PCR 
653 |a candidemia 
653 |a adaptive immunity 
653 |a fungal immunity 
653 |a T2 Candida 
653 |a anti-fungal agents 
653 |a innate immunity 
653 |a antifungal stewardship 
653 |a Immunotherapy 
653 |a Candida meningoencephalitis 
653 |a liposomal amphotericin B 
653 |a anidulafungin 
653 |a liver disease 
653 |a invasive mold disease 
653 |a T2Candida 
653 |a AIDS 
653 |a (1?3)-?-d-glucan 
653 |a literature review 
653 |a yeast 
653 |a hepatic impairment 
653 |a prediction models 
653 |a IRIS 
653 |a invasive aspergillosis 
653 |a antifungal agent 
653 |a TNF inhibitors 
653 |a Aspergillus fumigatus 
653 |a fungal nomenclature 
653 |a micafungin 
653 |a non-culture-based diagnostics 
653 |a PCR 
653 |a paracoccidioidomycosis 
653 |a Candida auris 
653 |a multidrug resistance 
653 |a subcutaneous mycoses 
653 |a risk score 
653 |a mycoses of implantation 
653 |a Sporothrix brasiliensis 
653 |a antifungal resistance 
653 |a immunocompromised hosts 
653 |a Sporothrix schenckii 
653 |a Aspergillus 
653 |a fungus 
653 |a cell therapy 
653 |a MALDI-ToF MS 
653 |a lateral flow 
653 |a phylogenetics 
653 |a hematological malignancy 
653 |a candidiasis 
653 |a antifungal drug 
653 |a hematological malignancies 
653 |a mycoses 
653 |a invasive fungal infections 
653 |a lymphoma 
653 |a kidney transplant 
653 |a immune reconstitution inflammatory syndrome 
653 |a mechanisms of antifungal resistance 
653 |a fungal infections 
653 |a cytokine therapy 
653 |a sporotrichosis 
653 |a beta-d-glucan 
653 |a invasive fungal infection 
653 |a HIV 
653 |a cat-transmitted sporotrichosis 
653 |a aspergillosis 
653 |a cancer 
653 |a prognostic risk model 
856 4 0 |a www.oapen.org  |u https://mdpi.com/books/pdfview/book/1195  |7 0  |z DOAB: download the publication 
856 4 0 |a www.oapen.org  |u https://directory.doabooks.org/handle/20.500.12854/48211  |7 0  |z DOAB: description of the publication